Waters omab hetkel AAQS väärtuseks 8. Kõrget AAQS-i võib pidada positiivseks märgiks, et ettevõte areneb edukalt. Investorid võivad eeldada, et ettevõte on heas seisus kasumi teenimiseks. Teisest küljest on oluline vaadelda Waters aktsia AAQS-i võrdluses saadud kasumite ja sama sektori teiste ettevõtetega. Kõrge AAQS ei ole absoluutne garantii positiivseks tulevikuks. Ainult nii on võimalik saada täielik ülevaade ettevõtte sooritusest. Ettevõtte arengu paremaks hindamiseks on oluline võrrelda AAQS-i sama sektori teiste ettevõtetega. Üldiselt peaksid investorid alati vaatlema ettevõtte AAQS-i seoses teiste näitajatega nagu kasum, EBIT, rahavoog ja muud, et teha põhjendatud investeerimisotsus.

Waters Aktienanalyse

Mis teeb Waters?

Waters Corporation is a leading company in the field of analytics and laboratory instruments. The company was founded in 1958 by James L. Waters and is headquartered in Milford, Massachusetts. Waters Corp originated from the development of liquid chromatography (LC), a technology that allows researchers to separate, identify and analyze substances in a sample. Over the years, Waters has built on this foundation and has evolved into a company that offers a wide range of solutions for the life science industry and chemical analysis. The business model of Waters Corp is based on the development and sale of innovative technologies and instruments for the analysis of chemical and biological substances. The company focuses on four main areas: life science mass spectrometry, chromatography, chemical analysis, and laboratory information systems. Life science mass spectrometry encompasses a range of technologies that facilitate the analysis of biological molecules and medical samples. Mass spectrometry is an instrument for measuring the mass of a molecule. It is used to determine the identity of compounds in a sample and provide information about their structure. Applications are diverse and range from the exploration of new drugs to the diagnosis of diseases. Chromatography systems allow researchers to split and identify substances in a sample. The company offers a wide range of solutions for liquid chromatography and gas chromatography, including systems for high-performance liquid chromatography (HPLC), ultra-high-performance liquid chromatography (UHPLC), and gas chromatography (GC). Chemical analysis encompasses a wide range of technologies that enable rapid, accurate, and reliable analysis of chemical substances. The company offers solutions for spectroscopy, nuclear magnetic resonance spectroscopy (NMR), and X-ray crystallography. Laboratory information systems enable effective management of laboratory information, including sample and result management, as well as report generation and data security. Waters offers solutions for laboratory information management systems (LIMS), electronic signature, and electronic archiving. The company has a wide range of products, including mass spectrometers, gas chromatographs, liquid chromatographs, laboratory information and chromatography software, accessories, and consumables. Waters' product range is focused on various applications in medical research, drug development, the food industry, environmental analysis, and other industries. Waters has a long history of innovation and has received numerous awards for its advancements in technology development and analytics. The company has become a global leader in analytical instruments, software products, and consumables, serving customers in more than 100 countries worldwide. Overall, Waters Corp has a strong position in the industry based on innovative technologies, broad performance spectrum, and decades of experience. The company is expected to continue playing an important role in the analytics and instruments industry, while focusing on the demand for accuracy, precision, and speed in the field of life science technology and chemistry. Waters ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Sagedased küsimused Waters aktsia kohta

Aktsiasäästuplaanid pakuvad investoritele atraktiivset võimalust pikema aja jooksul vara koguda. Üheks peamiseks eeliseks on nn keskmise maksumuse efekt: investeerides regulaarselt kindla summa aktsiatesse või aktsiafondidesse, ostetakse automaatselt rohkem osakuid siis, kui hinnad on madalad, ja vähem, kui need on kõrged. See võib aja jooksul viia soodsama keskmise hinna per osakuni. Lisaks võimaldavad aktsiasäästuplaanid ka väikeinvestoritel pääseda ligi kallimatele aktsiatele, kuna nendega saab liituda juba väikeste summadega. Regulaarne investeerimine soodustab ka distsiplineeritud investeerimisstrateegiat ja aitab vältida emotsionaalsete otsuste, nagu impulsiivne ostmine või müümine. Peale selle saavad investorid osa aktsiate võimalikust väärtuse kasvust ning dividendide väljamaksetest, mida saab reinvesteerida, mis tugevdab intressiintressi efekti ning seeläbi investeeritud kapitali kasvu.

Andere Kennzahlen von Waters

Meie Waters Käive-aktsia analüüs sisaldab olulisi finantsnäitajaid, nagu käive, kasum, P/E suhe, P/S suhe, EBIT, samuti teavet dividendi kohta. Lisaks käsitleme aspekte nagu aktsiad, turukapitalisatsioon, võlad, omakapital ja kohustused ettevõttes Waters Käive. Kui otsite nende teemade kohta põhjalikumat teavet, pakume teile meie alamlehtedel üksikasjalikke analüüse: